| Product Code: ETC9561993 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The import shipments of Sweden patient-derived xenograft (PDX) models in 2024 were mainly sourced from the Netherlands, USA, Norway (excluding Svalbard and Jan Mayen), Germany, and the UK. The Herfindahl-Hirschman Index (HHI) indicated low market concentration in 2024, fostering healthy competition. The compound annual growth rate (CAGR) from 2020 to 2024 stood at a robust 6.55%, with a notable growth rate of 9.49% from 2023 to 2024, reflecting a thriving market for PDX models in Sweden.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Patient Derived Xenograft (PDX) Models Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Patient Derived Xenograft (PDX) Models Market Revenues & Volume, 2022 & 2032F |
3.3 Sweden Patient Derived Xenograft (PDX) Models Market - Industry Life Cycle |
3.4 Sweden Patient Derived Xenograft (PDX) Models Market - Porter's Five Forces |
3.5 Sweden Patient Derived Xenograft (PDX) Models Market Revenues & Volume Share, By Type, 2022 & 2032F |
3.6 Sweden Patient Derived Xenograft (PDX) Models Market Revenues & Volume Share, By Tumor Type, 2022 & 2032F |
3.7 Sweden Patient Derived Xenograft (PDX) Models Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.8 Sweden Patient Derived Xenograft (PDX) Models Market Revenues & Volume Share, By Technique, 2022 & 2032F |
3.9 Sweden Patient Derived Xenograft (PDX) Models Market Revenues & Volume Share, By End User, 2022 & 2032F |
4 Sweden Patient Derived Xenograft (PDX) Models Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Growing demand for personalized medicine and targeted therapies |
4.2.2 Increasing prevalence of cancer and the need for more effective treatment options |
4.2.3 Technological advancements in the field of oncology research |
4.3 Market Restraints |
4.3.1 High cost associated with patient derived xenograft (PDX) models |
4.3.2 Ethical concerns related to the use of animals in research |
4.3.3 Limited availability of skilled professionals in the field of PDX model development |
5 Sweden Patient Derived Xenograft (PDX) Models Market Trends |
6 Sweden Patient Derived Xenograft (PDX) Models Market, By Types |
6.1 Sweden Patient Derived Xenograft (PDX) Models Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Sweden Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Type, 2022 - 2032F |
6.1.3 Sweden Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Mice Models, 2022 - 2032F |
6.1.4 Sweden Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Rat Models, 2022 - 2032F |
6.2 Sweden Patient Derived Xenograft (PDX) Models Market, By Tumor Type |
6.2.1 Overview and Analysis |
6.2.2 Sweden Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Gastrointestinal Tumor Models, 2022 - 2032F |
6.2.3 Sweden Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Lung Tumor Models, 2022 - 2032F |
6.2.4 Sweden Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Haematological Tumor Models, 2022 - 2032F |
6.3 Sweden Patient Derived Xenograft (PDX) Models Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Sweden Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Preclinical Drug Development, 2022 - 2032F |
6.3.3 Sweden Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Precision Medicine, 2022 - 2032F |
6.3.4 Sweden Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Co-Clinical Trials, 2022 - 2032F |
6.3.5 Sweden Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Basic Cancer Research, 2022 - 2032F |
6.3.6 Sweden Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Biomarker Analysis, 2022 - 2032F |
6.3.7 Sweden Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Oncology Research, 2022 - 2032F |
6.4 Sweden Patient Derived Xenograft (PDX) Models Market, By Technique |
6.4.1 Overview and Analysis |
6.4.2 Sweden Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Heterotopic Implantation, 2022 - 2032F |
6.4.3 Sweden Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Orthotropic Implantation, 2022 - 2032F |
6.5 Sweden Patient Derived Xenograft (PDX) Models Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 Sweden Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Academic and Research Organizations, 2022 - 2032F |
6.5.3 Sweden Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Contract Research Organizations, 2022 - 2032F |
6.5.4 Sweden Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Pharmaceutical and Biotechnological Companies, 2022 - 2032F |
6.5.5 Sweden Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Others, 2022 - 2032F |
7 Sweden Patient Derived Xenograft (PDX) Models Market Import-Export Trade Statistics |
7.1 Sweden Patient Derived Xenograft (PDX) Models Market Export to Major Countries |
7.2 Sweden Patient Derived Xenograft (PDX) Models Market Imports from Major Countries |
8 Sweden Patient Derived Xenograft (PDX) Models Market Key Performance Indicators |
8.1 Number of collaborations between research institutions and pharmaceutical companies for PDX model development |
8.2 Rate of adoption of PDX models in preclinical drug testing by pharmaceutical companies |
8.3 Number of research publications utilizing PDX models for cancer research |
8.4 Level of government funding allocated to support PDX model research and development efforts |
9 Sweden Patient Derived Xenograft (PDX) Models Market - Opportunity Assessment |
9.1 Sweden Patient Derived Xenograft (PDX) Models Market Opportunity Assessment, By Type, 2022 & 2032F |
9.2 Sweden Patient Derived Xenograft (PDX) Models Market Opportunity Assessment, By Tumor Type, 2022 & 2032F |
9.3 Sweden Patient Derived Xenograft (PDX) Models Market Opportunity Assessment, By Application, 2022 & 2032F |
9.4 Sweden Patient Derived Xenograft (PDX) Models Market Opportunity Assessment, By Technique, 2022 & 2032F |
9.5 Sweden Patient Derived Xenograft (PDX) Models Market Opportunity Assessment, By End User, 2022 & 2032F |
10 Sweden Patient Derived Xenograft (PDX) Models Market - Competitive Landscape |
10.1 Sweden Patient Derived Xenograft (PDX) Models Market Revenue Share, By Companies, 2025 |
10.2 Sweden Patient Derived Xenograft (PDX) Models Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here